CNS Pharmaceuticals, Inc.
SEC Filing List
CNSP CIK: 0001729427
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Cns Pharmaceuticals, Inc. | GlobalOne Filings, Inc. /fa | 05/26/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 05/26/2026 | ||
| 4 | Statement of changes in beneficial owner... | Charles Faith L. | GlobalOne Filings, Inc. /fa | 05/20/2026 | |
| S-3 | Registration statement for specified tra... | Cns Pharmaceuticals, Inc. | GlobalOne Filings, Inc. /fa | 05/19/2026 | |
| D | Official notice of an offering of securi... | GlobalOne Filings, Inc. /fa | 05/19/2026 | ||
| SCHEDULE 13G/A | SHARTSIS FRIESE LLP /fa | 05/15/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Cns Pharmaceuticals, Inc. | GlobalOne Filings, Inc. /fa | 05/14/2026 | |
| 8-K | Current report filing | Cns Pharmaceuticals, Inc. | GlobalOne Filings, Inc. /fa | 05/04/2026 | |
| SCHEDULE 13G | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/17/2026 | |||
| 10-K | Annual report pursuant to Section 13 and... | Cns Pharmaceuticals, Inc. | GlobalOne Filings, Inc. /fa | 03/31/2026 | |
| No record found. | |||||
| Load More | |||||
